Inotiv
Yahoo Finance • 2 months ago
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
– First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million – First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million – Conference call scheduled... Full story
Yahoo Finance • 2 months ago
Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026
WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services... Full story
Yahoo Finance • 4 months ago
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
– Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million – Fiscal 2025 revenue increased 4.5% to $513.0 million – Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million – Fiscal 2025 operating loss decreased... Full story
Yahoo Finance • 5 months ago
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025
WEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services... Full story
Yahoo Finance • 5 months ago
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results
Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 Million Updated Time of Company Presentation at Jefferies Global Healthcare Conference WEST LA... Full story
Yahoo Finance • 7 months ago
Inotiv files $350M mixed securities shelf
* Inotiv (NASDAQ:NOTV [https://seekingalpha.com/symbol/NOTV]) filed a prospectus for the offer and sale of $350M mixed securities shelf. * This prospectus is not an offer to sell these securities. * Filing. [https://seekingalpha.com... Full story
Yahoo Finance • 8 months ago
CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corrected. The corrected release follows: – Thi... Full story
Yahoo Finance • 8 months ago
Inotiv earnings missed by $0.12, revenue topped estimates
Investing.com - Inotiv (NASDAQ: NOTV) reported third quarter EPS of $-0.510, $0.12 worse than the analyst estimate of $-0.394. Revenue for the quarter came in at $130.7M versus the consensus estimate of $127.05M. Inotiv’s stock price clos... Full story
Yahoo Finance • 9 months ago
Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025
WEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services... Full story
Yahoo Finance • 11 months ago
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services a... Full story
Yahoo Finance • 12 months ago
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development service... Full story
Yahoo Finance • last year
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services... Full story
Yahoo Finance • 2 years ago
Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023
WEST LAFAYETTE, Ind., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm... Full story
Yahoo Finance • 2 years ago
Inotiv Provides Business Updates and Upcoming Investor Conferences Update
WEST LAFAYETTE, Ind., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela... Full story
Yahoo Finance • 2 years ago
Inotiv, Inc. to Participate in Upcoming Investor Conferences
WEST LAFAYETTE, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela... Full story
Yahoo Finance • 2 years ago
Inotiv, Inc. Announces Changes to its Board Composition
WEST LAFAYETTE, Ind., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization, today announced the appointment of Terry Coelho to its Board of Directors. Ms. Coelho is replacing Richard A.... Full story
Yahoo Finance • 3 years ago
Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.
WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm... Full story
Yahoo Finance • 3 years ago
Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences
WEST LAFAYETTE, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and developm... Full story
Yahoo Finance • 3 years ago
Inotiv, Inc. Expands Safety Pharmacology Offering to Include Cardiopulmonary Telemetry
WEST LAFAYETTE, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, and research models and rela... Full story
Yahoo Finance • 3 years ago
Inotiv, Inc. to Report Fiscal 2023 Second Quarter Financial Results and Host Conference Call on Thursday, May 11, 2023
WEST LAFAYETTE, Ind., April 26, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and develop... Full story
